SEARCH

SEARCH BY CITATION

References

  • 1
    Albright F. Case records of the Massachusetts General Hospital - Case 39061. N Engl J Med. 1941; 225: 78996.
  • 2
    Omenn GS, Roth SI, Baker WH. Hyperparathyroidism associated with malignant tumors of nonparathyroid origin. Cancer. 1969; 24: 100411.
  • 3
    Martin TJ, Atkins D. Biochemical regulators of bone resorption and their significance in cancer. Essays Med Biochem. 1979; 4: 4982.
  • 4
    Melick RA, Martin TJ, Hicks JD. Parathyroid hormone production and malignancy. Br Med J. 1972; 2: 2045.
  • 5
    Roof BS, Carpenter B, Fink DJ, Gordan GS. Some thoughts on the nature of ectopic parathyroid hormones. Am J Med. 1971; 50: 68691.
  • 6
    Benson RCJ, Riggs BL, Pickard BM, Arnaud CD. Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. J Clin Invest. 1974; 54: 17581.
  • 7
    Riggs BL, Arnaud CD, Reynolds JC, Smith LH. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest. 1971; 50: 207983.
  • 8
    Powell D, Singer FR, Murray TM, Minkin C, Potts JR. Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med. 1973; 289: 17681.
  • 9
    Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med. 1980; 303: 137783.
  • 10
    Kukreja SC, Shemerdiak WP, Lad TE, Johnson PA. Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer. J Clin Endocrinol Metab. 1980; 51: 1679.
  • 11
    Rude RK, Sharp CF, Fredericks RS, Oldham SB, Elbaum N, Link J, Irwin L, Singer FR. Urinary and nephrogenous adenosine 3′,5′-monophosphate in the hypercalcemia of malignancy. J Clin Endocrinol Metab. 1981; 52: 76571.
  • 12
    Rodan SB, Insogna KL, Vignery AM, Stewart AF, Broadus AE, D'Souza SM, Bertolini DR, Mundy GR, Rodan GA. Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. J Clin Invest. 1983; 72: 15115.
  • 13
    Stewart AF, Insogna KL, Goltzman D, Broadus AE. Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A. 1983; 80: 14548.
  • 14
    Strewler GJ, Williams RD, Nissenson RA. Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J Clin Invest. 1983; 71: 76974.
  • 15
    Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall REH, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajaz JD, Martin TJ. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A. 1987; 84: 504852.
  • 16
    Burtis WJ, Wu T, Bunch C, Wysolmerski JJ, Insogna KL, Weir EC, Broadus AE, Stewart AF. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem. 1987; 262: 71516.
  • 17
    Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Niseenson RA. Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest. 1987; 80: 18037.
  • 18
    Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, Hudson PJ, Martin TJ, Wood WI. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science. 1987; 237: 8937.
  • 19
    Mangin M, Webb AC, Dreyer BE, Posillico JT, Ikeda K, Weir EC, Stewart AF, Bander NH, Milstone L, Barton DE, Francke U, Broadus AE. Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A. 1988; 85: 597601.
  • 20
    Kemp BE, Moseley JM, Rodda CP, Ebeling PR, Wettenhall REH, Stapleton D, Diffenbach-Jagger H, Ure F, Michelangeli VP, Simmons HA, Raisz LG, Martin TJ. Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science. 1987; 238: 156870.
  • 21
    Jüppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF, Hock J, Potts JT, Kronenberg HM, Segre GV. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science. 1991; 254: 10246.
  • 22
    Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou-Samra AB, Jueppner H, Segre GV, Kronenberg HM. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science. 1996; 273: 6636.
  • 23
    Lanske B, Divieti P, Kovacs CS, Pirro A, Landis WJ, Krane SM, Bringhurst FR, Kronenberg HM. The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology. 1998; 139: 5194204.
  • 24
    Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest. 2005; 115: 240211.
  • 25
    Danks JA, Ho PM, Notini AJ, Katsis F, Hoffmann P, Kemp BE, Martin TJ, Zajac JD. Identification of a parathyroid hormone in the fish Fugu rubripes. J Bone Miner Res. 2003; 18: 132631.
  • 26
    Pinheiro PLC, Cardoso JCR, Gomes AS, Fuentes J, Power DM, Canário AVM. Gene structure, transcripts and calciotropic effects of the PTH family of peptides in Xenopus and chicken. BMC Evol Biol. 2010; 10: 373.
  • 27
    Okabe M, Graham A. The origin of the parathyroid gland. Proc Natl Acad Sci U S A. 2004; 101: 17716179.
  • 28
    Liu Y, Ibrahim AS, Tay B, Richardson SJ, Bell J, Walker TI, Brenner S, Venkatesh B, Danks JA. Parathyroid hormone gene family in a cartilaginous fish, the elephant shark (Callorhinshus milii). J Bone Miner Res. 2010; 25: 261323.
  • 29
    Burtis WJ, Fodero JP, Gaich G, Debeyssey M, Stewart AF. Preliminary characterization of circulating amino- and carboxy-terminal fragments of parathyroid hormone-related peptide in humoral hypercalcemia of malignancy. J Clin Endocrinol Metab. 1992; 75: 11104.
  • 30
    Grill V, Ho P, Body JJ, Johanson N, Lee SC, Krukreja SC, Moseley JM, Martin TJ. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab. 1991; 73: 130915.
  • 31
    Grill V, Hillary J, Ho PM, Law FM, MacIsaac RJ, MacIsaac IA, Moseley JM, Martin TJ. Parathyroid hormone-related protein: a possible endocrine function in lactation. Clin Endocrinol (Oxf). 1992; 37: 40510.
  • 32
    Rodda CP, Kubota M, Heath JA, Ebeling PR, Moseley JM, Care AD, Caple IW, Martin TJ. Evidence for a novel parathyroid hormone-related protein in fetal lamb parathyroid glands and sheep placenta: comparisons with a similar protein implicated in humoral hypercalcemia of malignancy. J Endocrinol. 1998; 117: 26171.
  • 33
    Kovacs CS, Lanske B, Hunzelman JL, Guo J, Karaplis AC, Kronenberg HM. Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci U S A. 1996; 93: 152338.
  • 34
    Richard V, Luchin A, Brena RM, Plass C, Rosol TJ. Quantitative evaluation of alternative promoter usage and 3′ splice variants for parathyroid hormone-related protein by real-time reverse transcription-PCR assay. Clin Chem. 2003; 49: 1398402.
  • 35
    Sellers RS, Luchin AI, Richard V, Brena RM, Lima D, Rosol TJ. Alternative splicing of parathyroid hormone-related protein mRNA: expression and stability. J Mol Endocrinol. 2004; 33: 22741.
  • 36
    Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev. 1996; 76: 12773.
  • 37
    Orloff JJ, Ganz MB, Nathanson MH, Moyer NS, Kats Y, Mitnick M, Behal A, Gasalla-Herraiz J, Isales CM. A midregion parathyroid hormone-related peptide mobilizes cytosolic calcium and stimulates formation of inositol trisphosphate in a squamous carcinoma cell line. Endocrinology. 1996; 137: 537685.
  • 38
    Wu TL, Soifer NE, Burtis WJ, Milstone LM, Stewart AF. Glycosylation of parathyroid hormone-related peptide secreted by human epidermal keratinocytes. J Clin Endocrinol Metab. 1991; 73: 10027.
  • 39
    Orloff JJ, Reddy D, de Papp AE, Yang KH, Soifer NE, Stewart AF. Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev. 1994; 15: 4060.
  • 40
    Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VLJ, Kronenberg HM, Mulligan RC. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 1994; 8: 27789.
  • 41
    Miao D, He B, Karaplis AC, Goltzman D. Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest. 2002; 109: 117382.
  • 42
    Amizuka N, Warshawsky H, Henderson JE, Goltzman D, Karaplis AC. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol. 1994; 126: 161123.
  • 43
    Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, Matsuki Y, Ejiri S, Tanaka M, Izumi N, Ozawa H, Goltzman D. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol. 1996; 175: 16676.
  • 44
    Kartsogiannis V, Moseley J, McKlevie B, Chou ST, Hards DK, Ng KW, Martin TJ, Zhou H. Temporal expression of PTHrP during endochondral bone formation in mouse and intramembranous bone formation in an in vivo rabbit model. Bone. 1997; 21: 38592.
  • 45
    Chen X, Macica CM, Dreyer BE, Hammond VE, Hens JR, Philbrick WM, Broadus AE. Initial characterization of PTH-related protein gene-driven lacZ expression in the mouse. J Bone Miner Res. 2006; 21: 11323.
  • 46
    Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg H. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest. 1999; 104: 399407.
  • 47
    Macica C, Liang G, Nasiri A, Broadus AE. Genetic evidence of the regulatory role of parathyroid hormone-related protein in articular chondrocyte maintenance in an experimental mouse model. Arthritis Rheum. 2011; 63: 333343.
  • 48
    Care AD, Abbas SK, Pickard DW, Barri M, Drinkhill M, Findlay JBC, White IR, Caple IW. Stimulation of ovine placental transport of calcium and magnesium by mid-molecule fragments of human parathyroid hormone-related protein. Exp Physiol. 1990; 75: 6058.
  • 49
    Wu TL, Vasavada RC, Yang K, Massfelder T, Ganz M, Abbas SK, Care AD, Stewart AF. Structural and physiologic characterization of the mid-region secretory species of parathyroid hormone-related protein. J Biol Chem. 1996; 271: 243718.
  • 50
    Simmonds CS, Kovacs CS. Role of parathyroid hormone (PTH) and PTH-related protein (PTHrP) in regulating mineral homeostasis during fetal development. Crit Rev Eukaryot Gene Expr. 2010; 20: 23573.
  • 51
    Charbon GA. A rapid and selective vasodilator effect of parathyroid hormone. Eur J Pharmacol. 1968; 3: 2758.
  • 52
    Charbon GA, Hulstaert PF. Augmentation of arterial hepatic and renal flow by extracted and synthetic parathyroid hormone. Endocrinology. 1974; 96: 6216.
  • 53
    Wang HH, Drugge ED, Yen YC, Blumenthal MR, Pang PK. Effects of synthetic parathyroid hormone on hemodynamics and regional blood flows. Eur J Pharmacol. 1984; 97: 20915.
  • 54
    Mok LLS, Nickols GA, Thompson JC, Cooper CW. Parathyroid hormone as a smooth muscle relaxant. Endocr Rev. 1989; 10: 42036.
  • 55
    Qian J, Lorenz JN, Maeda S, Sutliff RL, Weber C, Nakayama T, Colbert MC, Paul RJ, Fagin JA, Clemens TL. Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology. 1999; 140: 182633.
  • 56
    Martin TJ, Moseley JM, Williams ED. Parathyroid hormone-related protein: hormone and cytokine. J Endocrinol. 1997; 154: S2337.
  • 57
    Roca-Cusache A, Dipette DJ, Nickols GA. Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure. J Pharmacol Exp Ther. 1991; 256: 1108.
  • 58
    Pirola CJ, Wang HM, Kamyar A, Wu S, Enomoto H, Sharifi B, Forrester JS, Clemens TL, Fagin JA. Angiotensin II regulates parathyroid hormone-related protein expression in cultured rat aortic smooth muscle cells through transcriptional and post-transcriptional mechanisms. J Biol Chem. 1993; 268: 198794.
  • 59
    Wysolmerski JJ, McCaughern-Carucci JF, Daifotis AG, Broadus AE, Philbrick WM. Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development. 1995; 121: 353947.
  • 60
    Boras-Granic K, VanHouten J, Hiremath M, Wysolmerski JJ. Parathyroid hormone-related protein is not required for normal ductal or alveolar development in the post-natal mammary gland. PLoS One. 2011; 6: e27278.
  • 61
    Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, Erwert R, Pinkas J, Branstetter D, Dougall WC. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature. 2010; 468: 1037.
  • 62
    Philbrick WM, Dreyer BE, Nakchbandi IA, Karaplis AC. Parathyroid hormone-related protein is required for tooth eruption. Proc Natl Acad Sci U S A. 1998; 95: 1184651.
  • 63
    Beck F, Tucci J, Russell A, Senior PV, Ferguson MW. The expression of the gene coding for parathyroid hormone-related protein (PTHrP) during tooth development in the rat. Cell Tissue Res. 1995; 280: 28390.
  • 64
    Ouyang H, McCauley LK, Berry JE, D'Errico JA, Strayhorn CL, Somerman MJ. Response of immortalized murine cementoblasts/periodontal ligament cells to parathyroid hormone and parathyroid hormone-related protein in vitro. Arch Oral Biol. 2000; 45: 293303.
  • 65
    Ouyang H, McCauley LK, Berry JE, Saygin NE, Tokiyasu Y, Somerman MJ. PTHrP regulates extracellular matrix gene expression in cementoblasts and inhibits cementoblast-mediated mineralization, in vitro. J Bone Miner Res. 2000; 15: 214053.
  • 66
    Tenorio D, Hughes FJ. An immunohistochemical investigation of the expression of parathyroid hormone receptors in rat cementoblasts. Arch Oral Biol. 1996; 41: 299305.
  • 67
    Wysolmerski JJ, Cormier S, Philbrick WM, Dann P, Zhang JP, Roume J, Delezoide AL, Silve C. Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction. J Clin Endocrinol Metab. 2001; 86: 178894.
  • 68
    Wysolmerski JJ, Broadus AE, Zhou J, Fuchs E, Milstone LM, Philbrick WM. Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development. Proc Natl Acad Sci U S A. 1994; 91: 11337.
  • 69
    Werkmeister JR, Merryman JI, McCauley LK, Horton JE, Capen CC, Rosol TJ. Parathyroid hormone-related protein production by normal human keratinocytes in vitro. Exp Cell Res. 1993; 208: 6874.
  • 70
    Foley J, Longely BJ, Wysolmerski JJ, Dreyer BE, Broadus AE, Philbrick WM. PTHrP regulates epidermal differentiation in adult mice. J Invest Dermatol. 1998; 111: 11228.
  • 71
    Vasavada RC, Cavaliere C, D'Ercole AJ, Dann P, Burtis WJ, Madlener AL, Zawalich K, Zawalich W, Philbrick W, Stewart AF. Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia. J Biol Chem. 1996; 271: 12008.
  • 72
    Drucker DJ, Asa SL, Henderson J, Goltzman D. The parathyroid hormone-like peptide gene is expressed in the normal and neoplastic human endocrine pancreas. Mol Endocrinol. 2011; 3: 158995.
  • 73
    Guthalu Kondegowda N, Johshi-Gokhale S, Harb G, Williams K, Zhang XY, Takane KK, Zhang P, Scott DK, Stewart AF, Garcia-Ocana A, Vasavada RC. Parathyroid hormone-related protein enhances human β-cell proliferation and function with associated induction of cyclin-dependent kinase 2 and cyclin E expression. Diabetes. 2010; 59: 31318.
  • 74
    Cebrian A, Garcia-Ocana A, Takane KK, Sipula D, Stewart AR, Vasavada RC. Overexpression of parathryoid hormone-related protein inhibits pancreatic b-cell death in vivo and in vitro. Diabetes. 2002; 51: 300313.
  • 75
    Ureña P, Kong XF, Abou-Samra AB, Jüppner H, Kronenberg HM, Potts JR, Segre GV. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology. 1993; 133: 61723.
  • 76
    Henderson JE, Amizuka N, Warshawsky H, Biasotto D, Lanske BM, Goltzman D, Karaplis AC. Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol. 1995; 15: 406475.
  • 77
    Aarts MM, Davidson D, Corluka A, Petroulakis E, Guo J, Bringhurst FR, Galipeau J, Henderson JE. Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis. J Biol Chem. 2001; 276: 37943.
  • 78
    Okano K, Pirola CJ, Wang HM, Forrester JS, Fagin JA, Clemens TL. Involvement of cell cycle and mitogen-activated pathways in induction of parathyroid hormone-related protein gene expression in rat aortic smooth muscle cells. Endocrinology. 1995; 136: 178229.
  • 79
    Lam MH, Olsen SL, Rankin WA, Ho P, Martin TJ, Gillespie MT, Moseley JM. PTHrP and cell division: expression and localization of PTHrP in a keratinocyte cell line (HaCaT) during the cell cycle. J Cell Physiol. 1997; 173: 43346.
  • 80
    Lam MH, Thomas RJ, Martin TJ, Gillespie MT, Jans DA. Nuclear and nucleolar localization of parathyroid hormone-related protein. Immunol Cell Biol. 2000; 78: 395402.
  • 81
    Lam MH, House CM, Tiganis T, Mitchelhill KI, Sarcevic B, Cures A, Ramsay R, Kemp BE, Martin TJ, Gillespie MT. Phosphorylation at the cyclin-dependent kinases site (Thr85) of parathyroid hormone-related protein negatively regulates its nuclear localization. J Biol Chem. 1999; 274: 1855966.
  • 82
    Jans DA. The regulation of protein transport to the nucleus by phosphorylation. Biochem J. 1995; 311(Pt 3): 70516.
  • 83
    Lam MH, Briggs LJ, Hu W, Martin TJ, Gillespie MT, Jans DA. Importin beta recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin alpha. J Biol Chem. 1999; 274: 73918.
  • 84
    Jans DA, Thomas RJ, Gillespie MT. Parathyroid hormone-related protein (PTHrP): a nucleocytoplasmic shuttling protein with distinct paracrine and intracrine roles. Vitam Horm. 2003; 66: 34584.
  • 85
    Cingolani G, Bednenko J, Gillespie MT, Gerace L. Molecular basis for the recognition of a nonclassical nuclear localization signal by importin b. Mol Cell. 2002; 10: 134553.
  • 86
    De Miguel F, Fiaschi-Taesch NM, Lopez-Talavera JC, Takane KK, Massfelder T, Helwig JJ, Stewart AF. The C-terminal region of PTHrP, in addition to the nuclear localization signal, is essential for the intracrine stimulation of proliferation in vascular smooth muscle cells. Endocrinology. 2001; 142: 4096105.
  • 87
    Aarts MM, Rix A, Guo J, Bringhurst FR, Henderson JE. The nucleolar targeting signal (NTS) of parathyroid hormone related protein mediates endocytosis and nucleolar translocation. J Bone Miner Res. 1999; 14: 1493503.
  • 88
    Dougherty KM, Blomme EAG, Koh AJ, Henderson JE, Pienta KJ, Rosol TJ, McCauley LK. Parathyroid hormone related protein (PTHrP) as a growth regulator of prostate carcinoma. Cancer Res. 1999; 59: 601522.
  • 89
    Pache JC, Burton DW, Deftos LJ, Hastings RH. A carboxyl leucine-rich region of parathyroid hormone-related protein is critical for nuclear export. Endocrinology. 2007; 147: 9908.
  • 90
    Aarts MM, Levy D, He B, Stregger S, Chen T, Richard S, Henderson JE. Parathyroid hormone-related protein interacts with RNA. J Biol Chem. 1999; 274: 48328.
  • 91
    Miao D, Su H, He B, Gao J, Xia Q, Zhu M, Gu Z, Goltzman D, Karaplis AC. Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein. Proc Natl Acad Sci U S A. 2008; 105: 2030914.
  • 92
    Toribio RE, Brown HA, Novince CM, Marlow B, Hernon K, Lanigan LG, Hildreth BE, Werbeck JL, Shu ST, Lorch G, Carlton M, Foley J, Boyaka P, McCauley LK, Rosol TJ. The midregion, nuclear localization sequence and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice. FASEB J. 2010; 24: 194757.
  • 93
    Southby J, Kissin MW, Danks JA, Hayman JA, Moseley JM, Henderson MA, Bennett RC, Martin TJ. Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res. 1990; 50: 77106.
  • 94
    Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ. Localization of parathyroid hormone-related protein in breast cancer metastasis: increased incidence in bone compared with other sites. Cancer Res. 1991; 51: 305961.
  • 95
    Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, Yoneda T, Mundy GR. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest. 1996; 98: 15449.
  • 96
    Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002; 2: 58493.
  • 97
    Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T. Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer. 2000; 88: 2988.
  • 98
    Paget S. The distribution of secondary growths in cancer of the bones. Lancet. 1889; 1: 5713.
  • 99
    Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410: 506.
  • 100
    Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011; 11: 41125.
  • 101
    Li X, Loberg RD, Liao J, Ying C, Snyder LA, Pienta KJ, McCauley LK. A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone. Cancer Res. 2009; 69: 168592.
  • 102
    Deftos LJ, Barken I, Burton DW, Hoffman RM, Geller J. Direct evidence that PTHrP expression promotes prostate cancer progression in bone. Biochem Biophys Res Commun. 2005; 327: 46872.
  • 103
    Sourbier C, Massfelder T. Parathyroid hormone-related protein in human renal cell carcinoma. Cancer Lett. 2006; 240: 17082.
  • 104
    Shu ST, Dirksen WP, Lanigan LG, Martin CK, Thudi NK, Werbeck JL, Fernandez SA, Hildreth BE, Rosol TJ. Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro. Leuk Lymphoma. 2012; 53(4): 68898.
  • 105
    Henderson MA, Danks JA, Slavin JL, Byrnes GB, Choong PF, Spillane JB, Hopper JL, Martin TJ. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res. 2006; 66: 22506.
  • 106
    Henderson MA, Danks JA, Moseley JM, Slavin JL, Harris TL, McKinlay MR, Hopper JL, Martin TJ. Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases. J Natl Cancer Inst. 2001; 93: 2347.
  • 107
    Kissin MW, Henderson MA, Danks JA, Hayman JA, Bennett RC, Martin TJ. Parathyroid hormone related protein in breast cancers of widely varying prognosis. Eur J Surg Oncol. 1993; 19: 13442.
  • 108
    Bundred NJ, Walker RA, Ratcliffe WA, Warwick J, Morrison JM, Ratcliffe JG. Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer. 1992; 28: 6902.
  • 109
    Liapis H, Crouch EC, Grosso LE, Kitazawa S, Wick MR. Expression of parathyroid like protein in normal, proliferative and neoplastic human breast tissues. Am J Pathol. 1993; 143: 116978.
  • 110
    Bouizar Z, Spyratos F, De Vernejoul MC. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promoter and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis. J Bone Miner Res. 1999; 14: 40614.
  • 111
    Fleming NI, Trivett MK, George J, Slavin JL, Murray WK, Moseley JM, Anderson RL, Thomas DM. Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ. Cancer Res. 2009; 69: 74739.
  • 112
    Li J, Karaplis AC, Huang DC, Siegel PM, Camirand A, Yang XF, Muller WJ, Kremer R. PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target. J Clin Invest. 2011; 121: 465569.
  • 113
    VanHouten J, Dann P, Stewart AF, Watson C, Pollack M, Karaplis A, Wysolmerski JJ. Mammary-specific deletion of PTHrP reduces bone turnover and preserves bone mass during lactation. J Clin Invest. 2003; 112: 142936.
  • 114
    Chen H, Demiralp B, Schneider A, Koh AJ, Silve C, Wang CY, McCauley LK. Parathyroid hormone and parathyroid hormone related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem. 2002; 277: 1937481.
  • 115
    Hastings RH, Quintana RA, Sandoval R, Duey D, Yvette R, Burton DW, Deftos LJ. Proapoptotic effects of parathyroid hormone-related protein in type II pneumocytes. Am J Respir Cell Mol Biol. 2003; 29: 73342.
  • 116
    Turner PR, Mefford S, Christakos S, Nissenson RA. Apoptosis mediated by activation of the G protein coupled receptor. Mol Endocrinol. 2000; 14: 21454.
  • 117
    Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer. 2003; 3: 80721.
  • 118
    Wakefield LM, Roberts AB. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev. 2002; 12: 229.
  • 119
    Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR, Wakefield LM. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest. 2003; 112: 111624.